With the SPDR S&P Biotech Index up 34% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
http://www.insidermonkey.com/blog/osiris-therapeutics-inc-osir-glaxosmithkline-plc-adr-gsk-forest-laboratories-inc-frx-this-week-in-biotech-222603/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+InsiderMonkey+%28Insider+Monkey%29
http://www.insidermonkey.com/blog/osiris-therapeutics-inc-osir-glaxosmithkline-plc-adr-gsk-forest-laboratories-inc-frx-this-week-in-biotech-222603/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+InsiderMonkey+%28Insider+Monkey%29
No comments:
Post a Comment